Trends in Neurosciences
SpotlightTRPC5 and the path towards analgesic drug development
Section snippets
Acknowledgements
F.D. has received funding through an MRC New Investigator Research Grant (MR/P010814/1) and a Medical Research Foundation Prize (MRF-160-0015-ELP-DENK-C0844). She thanks Dr David Andersson for his insightful comments on this manuscript.
Declaration of interests
F.D. is on the Scientific Advisory Board of the Swedish pharmaceutical company Cellectricon.
References (9)
Human cells and networks of pain: transforming pain target identification and therapeutic development
Neuron
(2021)How can we improve the pre-clinical development of drugs for stroke?
Trends Neurosci.
(2007)Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019
Lancet
(2020)Transient receptor potential canonical 5 mediates inflammatory mechanical and spontaneous pain in mice
Sci. Transl. Med.
(2021)
Cited by (2)
Targeting ROS-sensitive TRP ion channels for relieving oxidative stress-related diseases based on nanomaterials
2023, Materials Today AdvancesCitation Excerpt :Activation of TRPC5 channels leads to cell membrane depolarization and intracellular Ca2+ concentration increase. TRPC5 channel is mainly expressed in brain tissue, and also distributes to a certain extent in liver, kidney and other organs, mediating a variety of physiological processes, and is related to the generation of fear, anxiety, depression and other emotions as well as progressive kidney disease (Fig. 13b) [75–78]. TRPC5 ion channels are closely related to the pathogenesis of familial focal segmental glomerulosclerosis (FSGS).
Synthesis of AC1903 analogs as potent transient receptor potential canonical channel 4/5 inhibitors and biological evaluation
2022, Bioorganic and Medicinal ChemistryCitation Excerpt :Based upon their sequence homology, TRPC are divided into two classes: TRPC1/4/5 and TRPC3/6/7,3 whereas TRPC2 is a pseudogene in humans.4 Recent studies have demonstrated that TRPC channels are important regulators in pathological processes, including focal segmental sclerosis (FSGS),5–9 cardiac plasticity,10 nociception,11 psoriasis,12,13 depression,14,15 neuronal development16–18 and tumor metastasis.19,20 Recent studies have focused on TRPC5 regulation of proteinuric kidney diseases.